MCPH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.045560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.819190E-01
Normal-vs-Stage2
1.018440E-01
Normal-vs-Stage3
6.620300E-02
Normal-vs-Stage4
6.155800E-01
Stage1-vs-Stage2
8.600200E-01
Stage1-vs-Stage3
2.223200E-01
Stage1-vs-Stage4
2.150800E-01
Stage2-vs-Stage3
3.361800E-01
Stage2-vs-Stage4
2.088000E-01
Stage3-vs-Stage4
2.150300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.150150E-01
Normal-vs-AfricanAmerican
3.156200E-01
Normal-vs-Asian
2.253500E-02
Caucasian-vs-AfricanAmerican
7.064000E-01
Caucasian-vs-Asian
2.205600E-01
AfricanAmerican-vs-Asian
2.047400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.322810E-01
Normal-vs-Female
8.486300E-02
Male-vs-Female
9.183200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.303960E-01
Normal-vs-Age(41-60Yrs)
1.203600E-01
Normal-vs-Age(61-80Yrs)
1.340770E-01
Normal-vs-Age(81-100Yrs)
6.917500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.121800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.245600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.771000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.155810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.350020E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.541900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.399500E-02
Normal-vs-Daily Drinker
9.719000E-03
Normal-vs-Weekly Drinker
2.453800E-01
Normal-vs-Occasional Drinker
2.652400E-01
Normal-vs-Social Drinker
3.656400E-01
Non Drinker-vs-Daily Drinker
5.919200E-01
Non Drinker-vs-Weekly Drinker
4.831000E-01
Non Drinker-vs-Occasional Drinker
6.640200E-02
Non Drinker-vs-Social Drinker
1.111210E-01
Daily Drinker-vs-Weekly Drinker
3.327400E-01
Daily Drinker-vs-Occasional Drinker
1.684230E-02
Daily Drinker-vs-Social Drinker
4.204200E-02
Weekly Drinker-vs-Occasional Drinker
4.719400E-01
Weekly Drinker-vs-Social Drinker
5.368400E-01
Occasional Drinker-vs-Social Drinker
9.987200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.554200E-01
Normal-vs-Grade 2
4.112100E-02
Normal-vs-Grade 3
3.954500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.038400E-01
Grade 1-vs-Grade 3
1.383770E-01
Grade 1-vs-Grade 4
2.554200E-01
Grade 2-vs-Grade 3
7.522000E-01
Grade 2-vs-Grade 4
4.112100E-02
Grade 3-vs-Grade 4
3.954500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.059820E-01
Normal-vs-NonDiabetic
7.692200E-02
Diabetic-vs-NonDiabetic
8.014200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.828500E-02
Normal-vs-NoPancreatitis
1.036220E-01
Pancreatitis-vs-NoPancreatitis
3.261600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.896850E-01
Normal-vs-N1
8.780000E-02
N0-vs-N1
8.619200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.264000E-01
Normal-vs-TP53-NonMutant
2.537600E-01
TP53-Mutant-vs-TP53-NonMutant
9.697600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
